Ann Collier

NPI: 1568548311
Total Payments
$1,908
2018 Payments
$1,025
Companies
5
Transactions
10

Payment Breakdown by Category

Consulting$1,595 (83.6%)
Food & Beverage$313.08 (16.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,595 5 83.6%
Food and Beverage $313.08 5 16.4%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme Corporation $1,715 6 $0 (2018)
Gilead Sciences, Inc. $110.59 1 $0 (2018)
Scilex Pharmaceuticals Inc. $49.15 1 $0 (2018)
ADAPT PHARMA INC. $21.69 1 $0 (2018)
Allergan Inc. $11.74 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2018 $1,025 7 Merck Sharp & Dohme Corporation ($832.00)
2017 $882.91 3 Merck Sharp & Dohme Corporation ($882.91)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/20/2018 Scilex Pharmaceuticals Inc. ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) Food and Beverage In-kind items and services $49.15 General
Category: Analgesic
10/10/2018 ADAPT PHARMA INC. Naloxone (Drug) Food and Beverage Cash or cash equivalent $21.69 General
Category: Opiod Overdose
06/12/2018 Gilead Sciences, Inc. Biktarvy (Drug) Food and Beverage In-kind items and services $110.59 General
Category: HIV
04/09/2018 Merck Sharp & Dohme Corporation DELSTRIGO (Drug) Consulting Fee Cash or cash equivalent $195.00 General
Category: INFECTIOUS DISEASE
03/09/2018 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $11.74 General
Category: HYPERHYDROSIS
01/26/2018 Merck Sharp & Dohme Corporation PIFELTRO (Drug) Consulting Fee Cash or cash equivalent $520.00 General
Category: INFECTIOUS DISEASE
01/24/2018 Merck Sharp & Dohme Corporation DELSTRIGO (Drug) Consulting Fee Cash or cash equivalent $117.00 General
Category: INFECTIOUS DISEASE
08/21/2017 Merck Sharp & Dohme Corporation ISENTRESS (Drug) Food and Beverage In-kind items and services $119.91 General
Category: INFECTIOUS DISEASE
04/11/2017 Merck Sharp & Dohme Corporation MK-1439A (Drug) Consulting Fee Cash or cash equivalent $438.00 General
Category: INFECTIOUS DISEASE
04/11/2017 Merck Sharp & Dohme Corporation MK-1439 (Drug) Consulting Fee Cash or cash equivalent $325.00 General
Category: INFECTIOUS DISEASE

About Ann Collier

Ann Collier is a Infectious Disease healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568548311.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ann Collier has received a total of $1,908 in payments from pharmaceutical and medical device companies, with $1,025 received in 2018. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,595).

Practice Information

  • Specialty Infectious Disease
  • Location Seattle, WA
  • Active Since 10/27/2006
  • Last Updated 01/23/2012
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1568548311

Products in Payments

  • PIFELTRO (Drug) $520.00
  • MK-1439A (Drug) $438.00
  • MK-1439 (Drug) $325.00
  • DELSTRIGO (Drug) $312.00
  • ISENTRESS (Drug) $119.91
  • Biktarvy (Drug) $110.59
  • ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $49.15
  • Naloxone (Drug) $21.69
  • BOTOX THERAPEUTIC (Biological) $11.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Seattle